HDL - Cholesterol: The New Target for Treatment
Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Ashraf Ganie
Pages 153-160 (8)
In spite of optimal treatment of LDL - cholesterol, as per evidence -based guidelines, only a one third reduction in cardiovascular risk is achieved in our patients. This has led to the realization that other types of cholesterol, too, need to be treated, in order to achieve ideal cardiovascular health. The review focuses on high density lipoprotein (HDL) cholesterol as a target for treatment, its importance, relevant patents and current as well as future treatments.
HDL cholesterol, hyperlipidemia, niacin, fibrates, statins
Bharti Hospital, Kunjpura Road, Karnal, 132001, Haryana, India.